Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

The Role of Epigenetics in Brain Aneurysm and Subarachnoid Hemorrhage, A Comprehensive Review

  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Vallverdú-Prats, Marta|||0000-0002-5262-817X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Bojtos, Lidia
  • Susin-Calle, Sílvia
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Guisado-Alonso, Daniel|||0000-0002-5799-3184
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
This comprehensive review explores the emerging field of epigenetics in intracranial aneurysm (IA) and aneurysmal subarachnoid hemorrhage (aSAH). Despite recent advancements, the high mortality of aSAH needs an understanding of its underlying pathophysiology, where epigenetics plays a crucial role. This review synthesizes the current knowledge, focusing on three primary epigenetic mechanisms: DNA methylation, non-coding RNA (ncRNA), and histone modification in IA and aSAH. While DNA methylation studies are relatively limited, they suggest a significant role in the pathogenesis and prognosis of IA and aSAH, highlighting differentially methylated positions in genes presumably involved in these pathologies. However, methodological limitations, including small sample sizes and a lack of diverse population studies, temper these results. The role of ncRNAs, particularly miRNAs, has been more extensively studied, but there are still few studies focused on histone modifications. Despite methodological challenges and inconsistent findings, these studies underscore the involvement of miRNAs in key pathophysiological processes, including vascular smooth muscle regulation and the inflammatory response. This review emphasizes methodological challenges in epigenetic research, advocating for large-scale epigenome-wide association studies integrating genetic and environmental factors, along with longitudinal studies. Such research could unravel the complex mechanisms behind IA and aSAH, guiding the development of targeted therapeutic approaches.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood DNA Methylation Analysis Reveals a Distinctive Epigenetic Signature of Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Vallverdú-Prats, Marta|||0000-0002-5262-817X
  • Pérez-Giraldo, Alberto
  • Viles-García, Marc
  • Peris-Subiza, Julia
  • Vidal-Notari, Sergio
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Guisado-Alonso, Daniel|||0000-0002-5799-3184
  • Esteller, M.|||0000-0003-4490-6093
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Ois, Angel|||0000-0002-1375-5950
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
Vasospasm is a potentially preventable cause of poor prognosis in patients with aneurysmal subarachnoid hemorrhage (aSAH). Epigenetics might provide insight on its molecular mechanisms. We aimed to analyze the association between differential DNA methylation (DNAm) and development of vasospasm. We conducted an epigenome-wide association study in 282 patients with aSAH admitted to our hospital. DNAm was assessed with the EPIC Illumina chip (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term vascular events after subarachnoid hemorrhage

  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Guimaraens, Leopoldo
  • Vivas, Elio
  • Saldaña, Jesus
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Revert-Barbera, Anna
  • Estragues-Gazquez, Isabel
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Rey-Álvarez, Lucía|||0000-0003-3000-4814
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Ois, Angel|||0000-0002-1375-5950
Background: Spontaneous subarachnoid hemorrhage (SAH) long-term risk is not well known. Our aims are: describing long-term vascular event (VE) incidence rates in SAH survivors; describing VE: ischemic and/or hemorrhagic; identifying independent association of factors related to VE; and analyzing the usefulness of factors to increase predictive ability. Methods: A prospective cohort study of consecutive patients admitted to Hospital del Mar with a diagnosis of SAH (n = 566) between January 2007 and January 2020 was carried out. They were followed up until January 2021. The study endpoint was a new VE in the follow-up. We calculated both incidence rates and cumulative rates at 5 years. Cox regression survival models including vascular risk factors with and without specific data of SAH disease were developed. We analyzed ROC curves of all multivariate models. Results: The analyzed cohort included 423 non-fatal SAH cases. Total patient-years were 2468.16 years. The average follow-up was 70.03 ± 43.14; range: 1-180 months. There were 49 VE detected in 47 patients, as 2 of them had more than 1 VE. Incidence rate was 0.020 events_per_patient/year, cumulative incidence at 5 years was 11.11%. The more frequent VE that we found were cerebrovascular (28/49), mainly ischemic (21/28). Disability after SAH and the presence of multiple aneurysms were independently associated with a VE risk and improved the predictive capacity of multivariate models (AUC 0.679 vs 0.764; p = 0.0062). Conclusions: We reported a low vascular risk after SAH. We have shown the usefulness of SAH factors to identify patients with a higher risk of VE.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

DNA methylation and stroke prognosis, an epigenome-wide association study

  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Lazcano, Uxue|||0000-0003-3948-3372
  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Vallverdú-Prats, Marta|||0000-0002-5262-817X
  • Mola-Caminal, Marina
  • Rey-Álvarez, Lucía|||0000-0003-3000-4814
  • Macias Gómez, Adrià|||0000-0003-0926-681X
  • Suárez-Pérez, Antoni|||0000-0002-0832-7580
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Ois, Angel|||0000-0002-1375-5950
  • Esteller, M.|||0000-0003-4490-6093
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
Background and aims: Stroke is the leading cause of adult-onset disability. Although clinical factors influence stroke outcome, there is a significant variability among individuals that may be attributed to genetics and epigenetics, including DNA methylation (DNAm). We aimed to study the association between DNAm and stroke prognosis. Methods and results: To that aim, we conducted a two-phase study (discovery-replication and meta-analysis) in Caucasian patients with ischemic stroke from two independent centers (BasicMar [discovery, N = 316] and St. Pau [replication, N = 92]). Functional outcome was assessed using the modified Rankin Scale (mRS) at three months after stroke, being poor outcome defined as mRS.
Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic Stroke

  • Fernández-Pérez, Isabel
  • Vallverdu-Prats, Marta
  • Rey-Álvarez, Lucía
  • Giralt Steinhauer, Eva
  • Ois, Angel
  • Cuadrado-Godia, Elisa
  • Rodríguez-Campello, Ana
  • Suárez-Pérez, Antoni
  • Macías-Gómez, Adrià
  • Soriano-Tárraga, Carolina
  • Purroy, Francisco F.
  • Arque, Gloria
  • Tur, Silvia
  • Cañellas, Guillem
  • Vives-Bauza, Cristòfol
  • Segura, Tomás
  • Serrano-Heras, Gemma
  • Lazcano, Uxue
  • Jiménez-Balado, Joan
  • Jiménez-Conde, Jordi
[eng] Background and Objectives: Post–ischemic stroke (IS) outcomes vary widely among individuals, independently of clinical factors. This variability could be related to epigenetic mechanisms that regulate biological processes involved in recovery after ischemia. While several microRNAs (miRNAs) and their target genes are implicated in the pathophysiology of IS, their role in functional outcomes remains unclear. Our aim is to identify potential miRNAs associated with the 3-month outcome in patients with IS. Methods: A discovery study was performed in patients with acute IS assessed at Hospital del Mar of Barcelona from 2009 to 2018. Main inclusion criteria were initial NIH Stroke Scale (NIHSS) score >2, hospital admission within 24 hours of IS onset, and previous functional independence. Poor 3-month outcome was defined as a modified Rankin Scale score >2. We performed miRNA next-generation sequencing on plasma samples obtained within 24 hours and performed a differential expression analysis for 2,083 miRNAs using the DESeq2 package. A replication stage was performed using real time–PCR in another multicenter cohort, with equivalent inclusion criteria and multivariate regression models. We also performed enrichment pathways analyses in both phases. Results: The discovery cohort included 215 patients with IS (mean age 74.7 ± 10.2 years, 54.9% male). Age, sex, and stroke severity (measured with the 24-hour NIHSS) were associated with the 3-month outcome (p < 0.05). After adjusting for these potential confounders, we found 74 miRNAs significantly associated (Q < 0.05) with the 3-month poor outcome. Pathway analysis revealed significant associations with pathways related to angiogenesis, neuronal morphogenesis, transforming growth factor β (TGF-β), endothelial development, and cognition. The replication included 191 patients (mean age 78.0 ± 6.0 years, 49.7% male). We analyzed 26 miRNAs selected from the discovery stage, and 5 miRNAs replicated their association with poor outcomes (p < 0.05, fold change >1.7): miR-376c-3p, miR-4463, miR-199a-3p, miR-584-5p, and miR-134-5p.